Evidence map›Paper›PMID 40920563›Full record

ArticleACS nano2025

Cobalt-Doped Carbon Quantum Dots Work Synergistically with Weak Acetic Acid to Eliminate Antimicrobial-Resistant Bacterial Infections.

Adam Truskewycz, Benedict Choi, Line Pedersen, Jianhua Han, Melanie MacGregor, Nils Halberg

Abstract read
In one paragraph

Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adam TruskewyczDepartment of Biomedicine, University of Bergen, Bergen 5009, Norway.ORCID 0000-0003-1454-962X
Benedict ChoiDepartment of Biomedicine, University of Bergen, Bergen 5009, Norway.
Line PedersenDepartment of Biomedicine, University of Bergen, Bergen 5009, Norway.
Jianhua HanDepartment of Biomedicine, University of Bergen, Bergen 5009, Norway.
Melanie MacGregorFlinders Institute for Nanoscale Science and Technology, College of Science and Engineering, Flinders University, Adelaide, South Australia 5042, Australia.ORCID 0000-0002-8671-181X
Nils HalbergDepartment of Biomedicine, University of Bergen, Bergen 5009, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When pathogenic bacteria colonize a wound, they can create an alkaline ecological niche that selects for their survival by creating an inflammatory environment restricting healthy wound healing to proceed. To aid healing, wound acidification has been exploited to disrupt this process and stimulate fibroblast growth, increase wound oxygen concentrations, minimize proteolytic activity, and restimulate the host immune system. Within this study, we have developed cobalt-doped carbon quantum dot nanoparticles that work together with mild acetic acid, creating a potent synergistic antimicrobial therapy. The acidic environment alters the osmotic balance of microorganisms, forcing them to swell and speed up the internalization of the ultrasmall particles. The particles hyperpolarize the bacterial membranes and generate damaging peroxidase species, resulting in cellular lysis. In mice, cobalt-doped carbon quantum dots remove MRSA infection while allowing wounds to heal at rates equivalent to that of uninfected wounds. This work demonstrates how synergistic antimicrobial treatment strategies can be successfully used to combat antimicrobial-resistant infections.

Indexed as

Acetic AcidAnti-Bacterial AgentsCarbonCobaltMethicillin-Resistant Staphylococcus aureusQuantum DotsStaphylococcal InfectionsAnimalsDrug Resistance, BacterialDrug SynergismHumansMiceMicrobial Sensitivity TestsWound HealingAcetic AcidAnti-Bacterial AgentsCarbonCobaltacetic acidantimicrobialantimicrobial resistantcarbon quantum dotcobaltnanoparticles

Identifiers

PMID40920563
PMCPMC12462238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.